Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Other Non Operating Income (2016 - 2026)

Tenax Therapeutics' Other Non Operating Income history spans 7 years, with the latest figure at $693941.0 for Q4 2017.

  • On a quarterly basis, Other Non Operating Income fell 49.17% to $693941.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $366215.0, a 74.78% decrease, with the full-year FY2025 number at -$33000.0, down 3400.0% from a year prior.
  • Other Non Operating Income hit $693941.0 in Q4 2017 for Tenax Therapeutics, up from -$76226.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for TENX hit a ceiling of $1.4 million in Q4 2016 and a floor of -$226914.0 in Q3 2016.
  • Historically, Other Non Operating Income has averaged $191169.7 across 4 years, with a median of $3468.0 in 2013.
  • The widest YoY moves for Other Non Operating Income: up 280.28% in 2016, down 223.59% in 2016.
  • Tracing TENX's Other Non Operating Income over 4 years: stood at $3468.0 in 2013, then skyrocketed by 10252.97% to $359041.0 in 2015, then surged by 280.28% to $1.4 million in 2016, then plummeted by 49.17% to $693941.0 in 2017.
  • Business Quant data shows Other Non Operating Income for TENX at $693941.0 in Q4 2017, -$76226.0 in Q3 2017, and -$28199.0 in Q2 2017.